Top Stories
Top Stories
Press Releases

World Glucose Self-Testing Markets

Globe Newswire

Dublin, Dec. 12, 2014 (GLOBE NEWSWIRE) -- Research and Markets ( announced the addition of the "World Glucose Self-Testing Markets" report to their offering.

The worldwide incidence of diabetes is dramatically increasing, and it is estimated that 439 million people will have developed the disease by 2030. As such, the global market for blood glucose self-testing products is undergoing a significant transition driven by the advent of new analytical technologies and new recommendations for tight glucose control for monitoring diabetes. In addition, the proliferation of the middle class within developing nations, particularly China and India, has resulted in both a substantial rise in Type 2 diabetes and the financial means to manage the disease.

The purpose of this report is to provide a comprehensive analysis of the specific segment of the over-the-counter diagnostics sector known as the glucose self-testing market. The term "self-testing" is used to distinguish it from in vitro diagnostics testing for blood glucose in hospitals, commercial labs and doctor's offices, the so-called "professional" component of the glucose testing market.

This study reviews the viable technology drivers and assesses the market dynamics of the glucose self-testing market worldwide. This report also looks at the industry challenges and potential threats, and it makes strategic recommendations for boosting market share. Detailed tables and charts with sales forecasts and market share data are also included.

Key Topics Covered:

1. Overview

2. Diabetes

3. Market Analysis: Size, Growth, Share and Competitors

4. Glucose Monitoring Recommendations

5. Glucose Self-testing Technology Platforms and Consumable Products

6. Glucose Self-testing Meters on the Market: Description of Test Meters

7. Business Trends in the Industry

8. Technology Trends

9. OTC Testing: Critical Issues

10. Current Issues for OTC and Diagnostic Self-testing

11. SWOT Analysis

12. Company Profiles

Companies Mentioned:

  • A. Menarini Diagnostics
  • A1c Self-testing
  • ACON Laboratories
  • Abbott (MediSense)
  • Agamatrix, Inc.
  • AiMedics
  • Allmedicus
  • Apex Biotechnology Corp.
  • Arkray, Inc.
  • Bayer
  • BioSense Medical Devices
  • BioTex
  • Bionime Corporation
  • Calisto Medical
  • Cygnus GlucoWatch Biographer
  • Diabetes Technologies
  • Diabetic Supply of Suncoast
  • Echo Therapeutics
  • Elektronika Kft.
  • Entra Health Systems
  • EyeSense GmbH
  • Fifty50 Pharmacy
  • Flexsite Diagnostics, Inc.
  • Fora Care
  • GenExel-Sein, Inc.
  • Glucoplus, Inc.
  • GlySens, Inc.
  • HemoCue
  • Heritage Labs
  • IN4 Technology Corporation
  • Integrity Applications Ltd.
  • Lein Applied Diagnostics
  • LifeScan
  • LighTouch Medical
  • Nipro Diagnostics, Inc.
  • Nova Biomedical
  • Oak Tree International Holdings, Inc.
  • OrSense Ltd.
  • Pepex Biomedical
  • Polymer Technology Systems
  • Prodigy Diabetes Care, LLC (an Affiliate of Diagnostic Devices, Inc.)
  • Roche Diagnostics Corporation
  • Smiths Medical MD, Inc.
  • Solianis Monitoring AG
  • TaiDoc Technology Corp.
  • U.S. Diagnostics
  • Ultradion
  • VeraLight
  • Xhale, Inc.
  • i-SENS

For more information visit

CONTACT: Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Home Testing, Glucose Testing

Source:Research and Markets